- Report
- October 2026
- 480 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 182 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 168 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 190 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 180 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 159 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 282 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 130 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 187 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 139 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 282 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 298 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 186 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 276 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 279 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 254 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 376 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 286 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 285 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 385 Pages
Global
From €5388EUR$5,850USD£4,554GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more